Crossject Société Anonyme (EPA:ALCJ)
1.380
-0.008 (-0.58%)
Sep 11, 2026, 5:38 PM CET
Crossject Société Anonyme Market Cap
Crossject Société Anonyme has a market cap or net worth of €75.13 million as of September 11, 2026. Its market cap has decreased by -4.26% in one year.
Market Cap
75.13M
Enterprise Value
92.50M
Revenue
2.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.38
ChartMarket Cap Chart
Since February 20, 2014, Crossject Société Anonyme's market cap has increased from 59.40M to 75.13M, an increase of 26.49%. That is a compound annual growth rate of 1.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 75.13M | -34.95% |
| Dec 31, 2025 | 115.50M | 10.53% |
| Dec 31, 2024 | 104.50M | -44.71% |
| Dec 29, 2023 | 188.99M | 90.83% |
| Dec 30, 2022 | 99.04M | 26.25% |
| Dec 31, 2021 | 78.44M | 0.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 88.14B |
| EssilorLuxottica Société anonyme | 67.03B |
| Sartorius Stedim Biotech | 18.18B |
| Ipsen | 12.82B |
| Guerbet | 94.61M |
| Eurofins-Cerep | 91.80M |
| Euroapi | 81.39M |
| ABIONYX Pharma | 77.90M |